Investigating human disease using stem cell models (original) (raw)

• Schwartz, P. H. et al. Neural progenitor cells from an adult patient with fragile X syndrome. BMC Med. Genet. 6, 2 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Haidet-Phillips, A. M. et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nature Biotech. 29, 824–828 (2011). In this study, neural progenitors were derived from a patient with ALS and differentiated into astrocytes that showed ALS-like neurotoxicity to co-cultured MNs.
  Article CAS Google Scholar
• Eiges, R. et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1, 568–577 (2007).
  Article CAS PubMed Google Scholar
• Niclis, J. C. et al. Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines. Front. Cell Neurosci. 7, 37 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Biancotti, J. C. et al. Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells 28, 1530–1540 (2010).
  Article CAS PubMed Google Scholar
• Mateizel, I. et al. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum. Reprod. 21, 503–511 (2006).
  Article CAS PubMed Google Scholar
• Marchetto, M. C. et al. Non-cell-autonomous effect of human SOD1G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649–657 (2008).
  Article CAS PubMed Google Scholar
• Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S. & Eggan, K. C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637–648 (2008). References 7 and 8 show a non-cell-autonomous effect of ALS-causing mutations in astrocytes on human stem-cell-derived MNs.
  Article CAS PubMed Google Scholar
• Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
  Article CAS PubMed Google Scholar
• Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007). References 9 and 10 report the first generation of iPSCs from human somatic cells.
  Article CAS PubMed Google Scholar
• Ebert, A. D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2009). This study is the first to show patient-specific iPSC-derived cells with disease-associated phenotypes.
  Article CAS PubMed Google Scholar
• HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11, 264–278 (2012).
  Article CAS Google Scholar
• Zhang, N., An, M. C., Montoro, D. & Ellerby, L. M. Characterization of human Huntington's disease cell model from induced pluripotent stem cells. PLoS Curr. 2, RRN1193 (2010).
  Article PubMed PubMed Central Google Scholar
• Chae, J. I. et al. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem. J. 446, 359–371 (2012).
  Article CAS PubMed Google Scholar
• Camnasio, S. et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol. Dis. 46, 41–51 (2012).
  Article CAS PubMed Google Scholar
• Jeon, I. et al. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells 30, 2054–2062 (2012).
  Article CAS PubMed Google Scholar
• Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010). This is the first report of an in vitro model of a cardiac disease using human iPSCs.
  Article CAS PubMed Google Scholar
• Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225–229 (2011).
  Article CAS PubMed Google Scholar
• Zhang, S. et al. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum. Mol. Genet. 20, 3176–3187 (2011).
  Article CAS PubMed Google Scholar
• Eggenschwiler, R. et al. Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy. Stem Cells Transl. Med. 2, 641–654 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ye, Z. et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114, 5473–5480 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, J. et al. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep. 3, 2088–2099 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Li, X. et al. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30, 1788–1797 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of _LRRK2_-associated Parkinson's disease: a case–control study. Lancet Neurol. 7, 583–590 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Trinh, J. et al. A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism. Neurobiol. Aging 35, 1125–1131 (2013).
  Article CAS PubMed Google Scholar
• Nguyen, H. N. et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267–280 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sanchez-Danes, A. et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol. Med. 4, 380–395 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kondo, T. et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell 12, 487–496 (2013). This study uses iPSCs from patients with different forms of genetic and sporadic AD to model AD pathology, test potential treatments and show differential responsiveness of the different patient groups.
  Article CAS PubMed Google Scholar
• Reinhardt, P. et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354–367 (2013). This paper shows that genetic correction of a LRRK2 mutation modifies the in vitro phenotypes in midbrain DANs that are associated with PD, including aberrant MAPK signalling and gene transcription.
  Article CAS PubMed Google Scholar
• Liu, G. H. et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 491, 603–607 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, J. D. et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691–705 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Dekker, P. et al. Chronic inhibition of the respiratory chain in human fibroblast cultures: differential responses related to subject chronological and biological age. J. Gerontol. A Biol. Sci. Med. Sci. 67, 456–464 (2012).
  Article CAS PubMed Google Scholar
• Noppe, G. et al. Rapid flow cytometric method for measuring senescence associated β-galactosidase activity in human fibroblasts. Cytometry A 75, 910–916 (2009).
  Article CAS PubMed Google Scholar
• Koch, P. et al. Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease. Nature 480, 543–546 (2011).
  Article CAS PubMed Google Scholar
• Yusa, K. et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391–394 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Choi, S. M. et al. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 57, 2458–2468 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Zou, J., Mali, P., Huang, X., Dowey, S. N. & Cheng, L. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118, 4599–4608 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. Genetic correction of beta-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res. 22, 637–648 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Fong, H. et al. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep. 1, 226–234 (2013).
  Article CAS Google Scholar
• An, M. C. et al. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11, 253–263 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Corti, S. et al. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci. Transl Med. 4, 165ra162 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• ISIS Pharmaceuticals. Press release: Data from ISIS-SMN Rx Phase 1 study in children with spinal muscular atrophy presented at the American Academy of Neurology Meeting [online], (2014).
• Ryan, S. D. et al. Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2–PGC1α transcription. Cell 155, 1351–1364 (2013). By using genetic targeting, this study shows that mutant SNCA leads to nitrosative stress, as well as to nitrosylation and thus inactivation of the neuroprotective MEF2–PGC-1α pathway. As nitrosative stress is a feature of many neurodegenerative diseases, this mechanism could apply to other disorders.
  Article CAS PubMed PubMed Central Google Scholar
• Ding, Q. et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12, 238–251 (2013).
  Article CAS PubMed Google Scholar
• Roelandt, P. et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J. Hepatol 57, 246–251 (2012).
  Article CAS PubMed Google Scholar
• Wu, X. et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 8, e1002617 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshida, T. et al. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem. Biophys. Res. Commun. 416, 119–124 (2011).
  Article CAS PubMed Google Scholar
• Schwartz, R. E. et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 109, 2544–2548 (2012).
  Article PubMed Google Scholar
• Penkert, R. R. & Kalejta, R. F. Human embryonic stem cell lines model experimental human cytomegalovirus latency. MBio 4, e00298–00213 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• D'Aiuto, L. et al. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS ONE 7, e49700 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hoing, S. et al. Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. Cell Stem Cell 11, 620–632 (2012). This study shows the feasibility of high-throughput screening using a stem-cell-based phenotypic assay with a complex co-culture system that models ALS. Hit compounds that acted through multiple mechanisms were identified.
  Article CAS PubMed Google Scholar
• Yang, Y. M. et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12, 713–726 (2013). Similarly to reference 51, this study uses a neurotrophin withdrawal stress paradigm to identify kenpaullone as a neuroprotective compound that inhibits HGK.
  Article CAS PubMed PubMed Central Google Scholar
• Braam, S. R. et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107–116 (2010).
  Article CAS PubMed Google Scholar
• Liang, P. et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 127, 1677–1691 (2013).
  Article CAS PubMed Google Scholar
• Poduri, A., Evrony, G. D., Cai, X. & Walsh, C. A. Somatic mutation, genomic variation, and neurological disease. Science 341, 1237758 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63–67 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Theka, I. et al. Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors. Stem Cells Transl. Med. 2, 473–479 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Han, D. W. et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10, 465–472 (2012).
  Article CAS PubMed Google Scholar
• Zwaka, T. P. & Thomson, J. A. Homologous recombination in human embryonic stem cells. Nature Biotech. 21, 319–321 (2003).
  Article CAS Google Scholar
• Heaney, J. D., Rettew, A. N. & Bronson, S. K. Tissue-specific expression of a BAC transgene targeted to the Hprt locus in mouse embryonic stem cells. Genomics 83, 1072–1082 (2004).
  Article CAS PubMed Google Scholar
• Xue, H. et al. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells 27, 1836–1846 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Song, H., Chung, S. K. & Xu, Y. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6, 80–89 (2010).
  Article CAS PubMed Google Scholar
• Goulburn, A. L. et al. A targeted NKX2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives. Stem Cells 29, 462–473 (2011).
  Article CAS PubMed Google Scholar
• Aizawa, E. et al. Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. Mol. Ther. 20, 424–431 (2012).
  Article CAS PubMed Google Scholar
• Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotech. 27, 851–857 (2009).
  Article CAS Google Scholar
• Hockemeyer, D. et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nature Biotech. 29, 731–734 (2011).
  Article CAS Google Scholar
• Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR–Cas nucleases in human cells. Nature Biotech. 31, 822–826 (2013).
  Article CAS Google Scholar
• Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380–1389 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nature Biotech. 31, 833–838 (2013).
  Article CAS Google Scholar
• Ding, Q. et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12, 393–394 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Kelly, R. D., Mahmud, A., McKenzie, M., Trounce, I. A. & St John, J. C. Mitochondrial DNA copy number is regulated in a tissue specific manner by DNA methylation of the nuclear-encoded DNA polymerase gamma A. Nucleic Acids Res. 40, 10124–10138 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Van Blerkom, J., Sinclair, J. & Davis, P. Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. Hum. Reprod. 13, 2857–2868 (1998).
  Article CAS PubMed Google Scholar
• Brenner, C. A., Barritt, J. A., Willadsen, S. & Cohen, J. Mitochondrial DNA heteroplasmy after human ooplasmic transplantation. Fertil. Steril. 74, 573–578 (2000).
  Article CAS PubMed Google Scholar
• Tachibana, M. et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153, 1228–1238 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Tachibana, M. et al. Towards germline gene therapy of inherited mitochondrial diseases. Nature 493, 627–631 (2013).
  Article CAS PubMed Google Scholar
• Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547–551 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Reinhardt, P. et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE 8, e59252 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Koch, P., Opitz, T., Steinbeck, J. A., Ladewig, J. & Brustle, O. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc. Natl Acad. Sci. USA 106, 3225–3230 (2009).
  Article PubMed Google Scholar
• Li, W. et al. Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc. Natl Acad. Sci. USA 108, 8299–8304 (2011).
  Article PubMed Google Scholar
• Cao, N. et al. Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res. 23, 1119–1132 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Cheng, X. et al. Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 10, 371–384 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hannan, N. R. et al. Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Rep. 1, 293–306 (2013).
  Article CAS Google Scholar
• Mummery, C. L. et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 111, 344–358 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481–484 (2013).
  Article CAS PubMed Google Scholar
• Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013).
  Article CAS PubMed Google Scholar
• Eiraku, M. et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472, 51–56 (2011). References 84–86 show proof of principle for organoid generation.
  Article CAS PubMed Google Scholar
• Nakano, T. et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10, 771–785 (2012).
  Article CAS PubMed Google Scholar
• Andrée, B., Bär, A., Haverich, A. & Hilfiker, A. Small intestinal submucosa segments as matrix for tissue engineering: review. Tissue Eng. Part B Rev. 19, 279–291 (2013).
  Article CAS PubMed Google Scholar
• Bhise, N. S. et al. Organ-on-a-chip platforms for studying drug delivery systems. J. Control Release http://dx.doi.org/10.1016/j.jconrel.2014.05.004 (2014).
• Botta-Orfila, T. et al. Age at onset in LRRK2-associated PD is modified by SNCA variants. J. Mol. Neurosci. 48, 245–247 (2012).
  Article CAS PubMed Google Scholar
• Rashid, S. T. et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120, 3127–3136 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Almeida, S. et al. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep. 2, 789–798 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sareen, D. et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl Med. 5, 208ra149 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Almeida, S. et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 126, 385–399 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Donnelly, C. J. et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415–428 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, H. et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14, 796–809 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Kiskinis, E. et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14, 781–795 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wainger, B. J. et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 7, 1–11 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Egawa, N. et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl Med. 4, 145ra104 (2012).
  Article CAS PubMed Google Scholar
• Bilican, B. et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl Acad. Sci. USA 109, 5803–5808 (2012).
  Article PubMed Google Scholar
• Serio, A. et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl Acad. Sci. USA 110, 4697–4702 (2013).
  Article PubMed Google Scholar
• Israel, M. A. et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482, 216–220 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mertens, J. et al. APP processing in human pluripotent stem cell-derived neurons is resistant to NSAID-based γ-secretase modulation. Stem Cell Rep. 1, 491–498 (2013).
  Article CAS Google Scholar
• Yagi, T. et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum. Mol. Genet. 20, 4530–4539 (2011).
  Article CAS PubMed Google Scholar
• Shi, Y. et al. A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci. Transl Med. 4, 124ra29 (2012).
  PubMed PubMed Central Google Scholar
• Jiang, Y. et al. Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease. Stem Cells 30, 599–611 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Novak, A. et al. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation. J. Cell. Mol. Med. 16, 468–482 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Fatima, A. et al. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell Physiol. Biochem. 28, 579–592 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kujala, K. et al. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS ONE 7, e44660 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, X. H. et al. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. Cell Calcium 54, 57–70 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Jung, C. B. et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol. Med. 4, 180–191 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sheridan, S. D. et al. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE 6, e26203 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Matsa, E. et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur. Heart J. 32, 952–962 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lahti, A. L. et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis. Model. Mech. 5, 220–230 (2012).
  Article CAS PubMed Google Scholar
• Bellin, M. et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J. 32, 3161–3175 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Egashira, T. et al. Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc. Res. 95, 419–429 (2012).
  Article CAS PubMed Google Scholar
• Terrenoire, C. et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J. Gen. Physiol. 141, 61–72 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Davis, R. P. et al. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 125, 3079–3091 (2012).
  Article PubMed Google Scholar
• Ma, D. et al. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int. J. Cardiol 168, 5277–5286 (2013).
  Article PubMed Google Scholar
• Quarto, N. et al. Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells. Proc. Natl Acad. Sci. USA 109, 215–220 (2012).
  Article PubMed Google Scholar
• Cooper, O. et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci. Transl Med. 4, 141ra90 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Orenstein, S. J. et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nature Neurosci. 16, 394–406 (2013).
  Article CAS PubMed Google Scholar
• Sanders, L. H. et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381–386 (2014).
  Article CAS PubMed Google Scholar
• Jiang, H. et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nature Commun. 3, 668 (2012).
  Article CAS Google Scholar
• Imaizumi, Y. et al. Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol. Brain 5, 35 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Seibler, P. et al. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 31, 5970–5976 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Byers, B. et al. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress. PLoS ONE 6, e26159 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yagi, T. et al. Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS ONE 7, e41572 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, H. P. et al. Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum. Mol. Genet. 20, 4851–4864 (2011).
  Article CAS PubMed Google Scholar
• Suzuki, T. et al. Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. Am. J. Respir. Crit. Care Med. 189, 183–193 (2014).
  CAS PubMed PubMed Central Google Scholar
• Lachmann, N. et al. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 189, 167–182 (2014).
  CAS PubMed Google Scholar
• Ananiev, G., Williams, E. C., Li, H. & Chang, Q. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS ONE 6, e25255 (2011). References 30, 39–41, 96–98, 123 and 132 show that genetic correction of a mutation that causes a neurodegenerative disease in patients leads to a phenotypic reversion in vitro.
  Article CAS PubMed PubMed Central Google Scholar
• Cheung, A. Y. et al. Isolation of _MECP2_-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 20, 2103–2115 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, K. Y., Hysolli, E. & Park, I. H. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc. Natl Acad. Sci. USA 108, 14169–14174 (2011).
  Article PubMed Google Scholar
• Brennand, K. J. et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221–225 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sareen, D. et al. Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS ONE 7, e39113 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, T. et al. Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient. Stem Cells 29, 2090–2093 (2011).
  Article CAS PubMed Google Scholar
• Pasca, S. P. et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Med. 17, 1657–1662 (2011).
  Article CAS PubMed Google Scholar
• Yazawa, M. et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230–234 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Krey, J. F. et al. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nature Neurosci. 16, 201–209 (2013).
  Article CAS PubMed Google Scholar